Hem › Major depression › Connecticut
Kliniska studier för Major depression i Connecticut
16 studier för Major depression söker deltagare vid platser i Connecticut.
Städer i Connecticut
Officiell studietext (engelska)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- UConn Health Center, Farmington
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Connecticut Health Center, Farmington
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07076407A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Connecticut School of Medicine Psychiatry Department, Farmington
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New Haven
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
RekryterarFas 2
Ålder 21 till 65 · Alla kön · Uppdaterad 6 maj 2026 · NCT05786066Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- Yale University, New Haven
RekryterarFas 1
Ålder 18 till 60 · Alla kön · Uppdaterad 6 maj 2026 · NCT05915013Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
RekryterarObservationsstudie
Ålder 18 till 40 · Alla kön · Uppdaterad 10 mars 2026 · NCT06740383Imaging Depression in Parkinson's Disease
- Yale University, New Haven
RekryterarFas 2Friska volontärer välkomna
Ålder 40 till 80 · Alla kön · Uppdaterad 10 mars 2026 · NCT06402955Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #122, Cromwell
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 20 jan. 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 214, Norwalk
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 24 juli 2025 · NCT05922878Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.